Since cancer stem cells play a pivotal role in the resistance to chemo- and radiotherapy, in tumor relapse and in metastases occurrence, blocking their self-renewal through NF-κB and STAT3 signaling inhibition could represent a novel therapeutic approach to improve the efficacy of chemo- and radiotherapy in the treatment of ATC patients (Figure 4). This evidence concerns the gene NFKB1 and cancer.